α‐Galactosylceramide‐driven expansion of human natural killer T cells is inhibited by prednisolone treatment
Summary The mechanisms of action of most treatments in the autoimmune disorders are unclear and steroids remain the first‐line therapy in these diseases. Natural killer T (NKT) cell activity has been implicated in the autoimmune process but whether steroids act via an affect on NKT cell function, su...
Saved in:
Published in | British journal of haematology Vol. 125; no. 3; pp. 400 - 404 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
01.05.2004
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
The mechanisms of action of most treatments in the autoimmune disorders are unclear and steroids remain the first‐line therapy in these diseases. Natural killer T (NKT) cell activity has been implicated in the autoimmune process but whether steroids act via an affect on NKT cell function, such as antigen‐specific proliferative capacity, is unknown. Immune thrombocytopenia (ITP) patients were studied ex vivo for NKT cell expansion in response to the specific NKT cell antigen, α‐galactosylceramide, before, during or after prednisolone treatment. Prednisolone inhibited antigen‐specific NKT cell expansion in ITP patients in remission. Untreated ITP patients also showed reduced NKT cell proliferative capacity, although this was less marked than in treated patients. These results support a role for NKT cells in ITP and aid understanding of the immunosuppressive activities of prednisolone in autoimmune disease. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0007-1048 1365-2141 |
DOI: | 10.1111/j.1365-2141.2004.04896.x |